Schedule of Segment Reporting Information |
| | | | | | | | | | | | | | | | | | | Total Revenues by Segment | For the three months ended June 30 | | For the six months ended June 30 | | 2025 | 2024 | | 2025 | 2024 | | Total Imaging | $ | 2,204 | | $ | 2,171 | | | $ | 4,344 | | $ | 4,233 | | | AVS: | | | | | | | Procedural Guidance | 660 | | 668 | | | 1,301 | | 1,319 | | | Specialized Ultrasound | 630 | | 581 | | | 1,228 | | 1,156 | | | Total AVS | 1,289 | | 1,249 | | | 2,529 | | 2,475 | | | PCS: | | | | | | | Monitoring Solutions | 578 | | 538 | | | 1,135 | | 1,065 | | | Life Support Solutions | 200 | | 235 | | | 397 | | 454 | | | Total PCS | 778 | | 772 | | | 1,531 | | 1,519 | | | Total PDx | 729 | | 639 | | | 1,362 | | 1,238 | | | Other(1) | 6 | | 9 | | | 19 | | 24 | | | Total revenues | $ | 5,007 | | $ | 4,839 | | | $ | 9,784 | | $ | 9,489 | | | | | | | | | |
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”) which does not meet the definition of an operating segment.
| | | | | | | | | | | | | | | | | | | Significant Expenses by Segment | For the three months ended June 30 | | For the six months ended June 30 | | 2025 | 2024 | | 2025 | 2024 | | Imaging: | | | | | | | Cost of sales | $ | 1,470 | | $ | 1,393 | | | $ | 2,823 | | $ | 2,731 | | | Other segment items(1) | 546 | | 569 | | | 1,135 | | 1,129 | | | Total Imaging | $ | 2,016 | | $ | 1,963 | | | $ | 3,957 | | $ | 3,860 | | | AVS: | | | | | | | Cost of sales | $ | 637 | | $ | 611 | | | $ | 1,235 | | $ | 1,209 | | | Other segment items(1) | 386 | | 382 | | | 766 | | 754 | | | Total AVS | $ | 1,022 | | $ | 993 | | | $ | 2,001 | | $ | 1,963 | | | PCS: | | | | | | | Cost of sales | $ | 507 | | $ | 480 | | | $ | 988 | | $ | 939 | | | Other segment items(1) | 212 | | 215 | | | 436 | | 421 | | | Total PCS | $ | 719 | | $ | 694 | | | $ | 1,423 | | $ | 1,360 | | | PDx: | | | | | | | Cost of sales | $ | 371 | | $ | 314 | | | $ | 666 | | $ | 609 | | | Other segment items(1) | 144 | | 125 | | | 278 | | 251 | | | Total PDx | $ | 516 | | $ | 439 | | | $ | 943 | | $ | 860 | | |
(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses. | | | | | | | | | | | | | | | | | | | Segment EBIT | For the three months ended June 30 | | For the six months ended June 30 | | 2025 | 2024 | | 2025 | 2024 | | Segment EBIT | | | | | | | Imaging | $ | 188 | | $ | 208 | | | $ | 387 | | $ | 373 | | | AVS | 267 | | 255 | | | 528 | | 512 | | | PCS | 60 | | 78 | | | 108 | | 159 | | | PDx | 213 | | 200 | | | 418 | | 378 | | | Other(1) | 1 | | 1 | | | 3 | | 1 | | | | 729 | | 742 | | | 1,443 | | 1,423 | | | Restructuring costs | (18) | | (29) | | | (40) | | (68) | | | Acquisition and disposition-related benefits (charges) | (7) | | 3 | | | (15) | | 3 | | | Gain (loss) on business and asset dispositions | (5) | | — | | | 5 | | — | | | Spin-Off and separation costs | (5) | | (67) | | | (29) | | (126) | | | Amortization of acquisition-related intangible assets | (40) | | (35) | | | (75) | | (66) | | | Investment revaluation gain (loss) | (1) | | (6) | | | 92 | | (26) | | | Interest and other financial charges – net | (113) | | (131) | | | (224) | | (254) | | | Non-operating benefit income (costs) | 73 | | 101 | | | 148 | | 204 | | | Income before income taxes | $ | 613 | | $ | 578 | | | $ | 1,304 | | $ | 1,090 | | |
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.
The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.
| | | | | | | | | | | | | | | | | | | Depreciation and Amortization by Segment | For the three months ended June 30 | | For the six months ended June 30 | | 2025 | 2024 | | 2025 | 2024 | | | | | | | | | Imaging | $ | 58 | | $ | 63 | | | $ | 115 | | $ | 128 | | | AVS | 18 | | 20 | | | 36 | | 40 | | | PCS | 13 | | 14 | | | 27 | | 29 | | | PDx | 17 | | 15 | | | 29 | | 31 | | | | | | | | | | | | | | | | |
|